Psychopharmacology

, Volume 222, Issue 1, pp 99–115 | Cite as

5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice

  • Virginie Da Silva Costa-Aze
  • Anne Quiedeville
  • Michel Boulouard
  • François Dauphin
Original Investigation

Abstract

Rationale

Blockade of 5-HT6 receptors (5-HT6R) is known to improve cognitive performances in the rodent. This improvement has been hypothesized to be the result, at least in part, of a modulation of the cholinergic neurotransmission.

Objective

We assessed the effects of 5-HT6R blockade on selected types of memory relevant to functional deficits of ageing and neurodegenerative diseases, in mice that present a scopolamine-induced cholinergic disruption of memory.

Method

Following the selection of an adequate dose of scopolamine to induce cognitive deficits, we have studied the effects of the selective 5-HT6R antagonist SB-271046, alone or in combination with scopolamine, on working memory (spontaneous alternation task in the T-maze), recognition memory (place recognition) and aversive learning (passive avoidance).

Results

SB-271046 alone failed to affect working memory, recognition memory and aversive learning performances. In contrast, SB-271046 was able to reverse the scopolamine-induced deficits in working memory (only at 30 mg kg−1) and those of acquisition and retrieval of aversive learning (dose-dependent effect); scopolamine-induced deficits in episodic-like memory (acquisition and retrieval) were partially counteracted by 5-HT6R blockade.

Conclusion

The modulation between 5-HT6R and the cholinergic system appears to be predominant for working memory and aversive learning, but not for other types of memory (i.e. episodic-like memory). Interactions between 5-HT6R and alternative neurotransmission systems (i.e. glutamatergic system) should be further studied. The respective involvement of these interactions in the memory disorders related to ageing and neurodegenerative diseases is of pivotal importance regarding the possible use of 5-HT6R antagonists in the treatment of memory disorders in humans.

Keywords

SB-271046 Scopolamine Working memory Recognition memory Aversive learning Spontaneous alternation Place recognition Passive avoidance Mouse 

Notes

Acknowledgements

The authors thank Prof. Frédéric Fabis and Dr. Magalie Paillet-Loilier (CERMN, Caen) for the synthesis of SB-271046, and Christiane Cliquet, Claudine Fauchon, Jérôme Anfray and Victoria Phamba for technical assistance. Virginie Da Silva Costa-Aze was supported by funding from the French Ministry of Research.

Conflicts of interest

The authors report no conflict of interest.

Supplementary material

213_2011_2627_MOESM1_ESM.docx (44 kb)
ESM 1 (DOCX 44 kb)
213_2011_2627_MOESM2_ESM.docx (64 kb)
ESM 2 (DOCX 64 kb)

References

  1. Bazin MA, El Kihel L, Boulouard M, Bouet V, Rault S (2009) The effects of DHEA, 3beta-hydroxy-5alpha-androstane-6,17-dione, and 7-amino-DHEA analogues on short term and long term memory in the mouse. Steroids 74:931–937PubMedCrossRefGoogle Scholar
  2. Boissier JR, Simon P (1965) Action of caffeine on the spontaneous motility of the mouse. Arch Int Pharmacodyn Ther 158:212–221PubMedGoogle Scholar
  3. Bontempi B, Whelan KT, Risbrough VB, Lloyd GK, Menzaghi F (2003) Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors. Neuropsychopharmacology 28:1235–1246PubMedCrossRefGoogle Scholar
  4. Cassel JC, Jeltsch H (1995) Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience 69:1–41PubMedCrossRefGoogle Scholar
  5. Costall B, Jones BJ, Kelly ME, Naylor RJ, Tomkins DM (1989) Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 32:777–785PubMedCrossRefGoogle Scholar
  6. Da Silva Costa V, Duchatelle P, Boulouard M, Dauphin F (2009) Selective 5-HT6 receptor blockade improves spatial recognition memory and reverses age-related deficits in spatial recognition memory in the mouse. Neuropsychopharmacology 34:488–500PubMedCrossRefGoogle Scholar
  7. Da Silva Costa-Aze V, Dauphin F, Boulouard M (2011) Selective 5-HT6 receptor blockade reverses the age-related deficits of recognition memory and working memory in mice. Behav Brain Res 222:134–140PubMedCrossRefGoogle Scholar
  8. Dawson LA, Nguyen HQ, Li P (2000) In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Br J Pharmacol 130:23–26Google Scholar
  9. Dawson LA, Nguyen HQ, Li P (2001) The 5-HT(6) receptor antagonist SB-271046 selec- tively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 25:662–668Google Scholar
  10. de Bruin NMWJ, Prickaerts J, van Loevezijn A, Venhorst J, de Groote L, Houba P, Reneerkens O, Akkerman S, Kruse CG (2011) Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats. Neurobiol Learn Mem 96:392–402PubMedCrossRefGoogle Scholar
  11. Decker MW, McGaugh JL (1991) The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7:151–168PubMedCrossRefGoogle Scholar
  12. Deiana S, Harrington CR, Wischik CM, Riedel G (2009) Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine. Psychopharmacology (Berl) 202:53–65CrossRefGoogle Scholar
  13. Dellu F, Mayo W, Cherkaoui J, Le Moal M, Simon H (1992) A two-trial memory task with automated recording: study in young and aged rats. Brain Res 588:132–139PubMedCrossRefGoogle Scholar
  14. Dellu F, Contarino A, Simon H, Koob GF, Gold LH (2000) Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiol Learn Mem 73:31–48PubMedCrossRefGoogle Scholar
  15. Dember WN, Fowler H (1958) Spontaneous alternation behavior. Psychol Bull 55:412–428PubMedCrossRefGoogle Scholar
  16. Dudchenko PA (2004) An overview of the tasks used to test working memory in rodents. Neurosci Biobehav Rev 28:699–709PubMedCrossRefGoogle Scholar
  17. Eriksson TM, Madjid N, Elvander-Tottie E, Stiedl O, Svenningsson P, Ogren SO (2008) Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission. Neuropharmacology 54:1041–1050PubMedCrossRefGoogle Scholar
  18. Fleischman DA, Gabrieli J (1999) Long-term memory in Alzheimer's disease. Curr Opin Neurobiol 9:240–244PubMedCrossRefGoogle Scholar
  19. Foley AG, Murphy KJ, Hirst WD, Gallagher HC, Hagan JJ, Upton N, Walsh FS, Regan CM (2004) The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats. Neuropsychopharmacology 29:93–100PubMedCrossRefGoogle Scholar
  20. Gravius A, Lasly J, Pietraszek M, Saghy K, Nagel J, Chambon C, Wegener N, Valastro B, Danysz W, Gyertyan I (2011) Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used the detection of cognitive enhancement and antipsychotic-like activity. Behav Pharmacol 22:122–135PubMedCrossRefGoogle Scholar
  21. Hamon M, Doucet E, Lefevre K, Miquel MC, Lanfumey L, Insausti R, Frechilla D, Del Rio J, Verge D (1999) Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptors. Neuropsychopharmacology 21:68S–76SPubMedGoogle Scholar
  22. Hasselmo ME, Sarter M (2011) Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology 36:52–73PubMedCrossRefGoogle Scholar
  23. Hirst WD, Abrahamsen B, Blaney FE, Calver AR, Aloj L, Price GW, Medhurst AD (2003) Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. Mol Pharmacol 64:1295–1308PubMedCrossRefGoogle Scholar
  24. Hirst WD, Stean TO, Rogers DC, Sunter D, Pugh P, Moss SF, Bromidge SM, Riley G, Smith DR, Bartlett S, Heidbreder CA, Atkins AR, Lacroix LP, Dawson LA, Foley AG, Regan CM, Upton N (2006) SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models. Eur J Pharmacol 553:109–119PubMedCrossRefGoogle Scholar
  25. Jarvik ME, Kopp R (1967) An improved one-trial passive avoidance learning situation. Psychol Rep 21:221–224PubMedCrossRefGoogle Scholar
  26. King MV, Sleight AJ, Woolley ML, Topham IA, Marsden CA, Fone KC (2004) 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation–an effect sensitive to NMDA receptor antagonism. Neuropharmacology 47:195–204PubMedCrossRefGoogle Scholar
  27. King MV, Marsden CA, Fone KC (2008) A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol Sci 29:482–492PubMedCrossRefGoogle Scholar
  28. Klinkenberg I, Blokland A (2010) The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev 34:1307–1350PubMedCrossRefGoogle Scholar
  29. Klinkenberg I, Blokland A (2011) A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment. Psychopharmacology (Berl) 215:549–566CrossRefGoogle Scholar
  30. Lelong V, Lhonneur L, Dauphin F, Boulouard M (2003) BIMU 1 and RS 67333, two 5-HT4 receptor agonists, modulate spontaneous alternation deficits induced by scopolamine in the mouse. Naunyn Schmiedebergs Arch Pharmacol 367:621–628PubMedCrossRefGoogle Scholar
  31. Lelong-Boulouard V, Quentin T, Moreaux F, Debruyne D, Boulouard M, Coquerel A (2006) Interactions of buprenorphine and dipotassium clorazepate on anxiety and memory functions in the mouse. Drug Alcohol Depend 85:103–113PubMedCrossRefGoogle Scholar
  32. Lieben CK, Blokland A, Sik A, Sung E, van Nieuwenhuizen P, Schreiber R (2005) The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat. Neuropsychopharmacology 30:2169–2179PubMedCrossRefGoogle Scholar
  33. Lindeboom J, Weinstein H (2004) Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment. Eur J Pharmacol 490:83–86PubMedCrossRefGoogle Scholar
  34. Marcos B, Gil-Bea FJ, Hirst WD, Garcia-Alloza M, Ramirez MJ (2006) Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release. Eur J Neurosci 24:1299–1306PubMedCrossRefGoogle Scholar
  35. Marcos B, Chuang TT, Gil-Bea FJ, Ramirez MJ (2008) Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat. Br J Pharmacol 155:434–440PubMedCrossRefGoogle Scholar
  36. Marcy R, Quermonne MA (1975) Benzodiazepines: a comparison of their effects in mice on the magnitude of the palmar skin conductivity response and on pentylenetetrazole-induced seizures. Experientia 31:954–955PubMedCrossRefGoogle Scholar
  37. Marcy R, Quermonne MA, Nammathao B (1976) Habituation to iterative photostimulation in the palmar skin conductance response of mice, its delay by psychoanaleptics. Experientia 32:208–209PubMedCrossRefGoogle Scholar
  38. Mitchell ES, Hoplight BJ, Lear SP, Neumaier JF (2006) BGC20-761, a novel tryptamine analog, enhances memory consolidation and reverses scopolamine-induced memory deficit in social and visuospatial memory tasks through a 5-HT6 receptor-mediated mechanism. Neuropharmacology 50:412–420PubMedCrossRefGoogle Scholar
  39. Otano A, Frechilla D, Cobreros A, Cruz-Orive LM, Insausti A, Insausti R, Hamon M, Del Rio J (1999) Anxiogenic-like effects and reduced stereological counting of immunolabelled 5-hydroxytryptamine6 receptors in rat nucleus accumbens by antisense oligonucleotides. Neuroscience 92:1001–1009PubMedCrossRefGoogle Scholar
  40. Perez-Garcia G, Meneses A (2005) Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task. Pharmacol Biochem Behav 81:673–682PubMedCrossRefGoogle Scholar
  41. Pitsikas N, Zisopoulou S, Pappas I, Sakellaridis N (2008) The selective 5-HT(6) receptor antagonist Ro 04-6790 attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801. Behav Brain Res 188:304–309PubMedCrossRefGoogle Scholar
  42. Richman CL, Dember WN, Kim P (1986) Spontaneous alternation behavior in animals: a review. Curr Psychol Res Rev 5:358–391CrossRefGoogle Scholar
  43. Riemer C, Borroni E, Levet-Trafit B, Martin JR, Poli S, Porter RH, Bos M (2003) Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist. J Med Chem 46:1273–1276PubMedCrossRefGoogle Scholar
  44. Rogers DC, Hagan JJ (2001) 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology (Berl) 158:114–119CrossRefGoogle Scholar
  45. Rush DK (1988) Scopolamine amnesia of passive avoidance: a deficit of information acquisition. Behav Neural Biol 50:255–274PubMedCrossRefGoogle Scholar
  46. Schliebs R, Arendt T (2006) The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm 113:1625–1644PubMedCrossRefGoogle Scholar
  47. Schreiber R, Vivian J, Hedley L, Szczepanski K, Secchi RL, Zuzow M, van Laarhoven S, Moreau JL, Martin JR, Sik A, Blokland A (2007) Effects of the novel 5-HT(6) receptor antagonist RO4368554 in rat models for cognition and sensorimotor gating. Eur Neuropsychopharmacology 17:277–288CrossRefGoogle Scholar
  48. Shirazi-Southall S, Rodriguez DE, Nomikos GG (2002) Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26:583–594PubMedCrossRefGoogle Scholar
  49. Sridhar N, Veeranjaneyulu A, Arulmozhi DK, Gupta CN, Babu RJ (2002) 5-HT3 receptors in selective animal models of cognition. Indian J Exp Biol 40(2):174–180PubMedGoogle Scholar
  50. Steckler T, Sahgal A (1995) The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav Brain Res 67:165–199PubMedCrossRefGoogle Scholar
  51. Steckler T, Drinkenburg WH, Sahgal A, Aggleton JP (1998) Recognition memory in rats–II. Neuroanatomical substrates. Prog Neurobiol 54:313–332PubMedCrossRefGoogle Scholar
  52. Svenningsson P, Tzavara ET, Qi H, Carruthers R, Witkin JM, Nomikos GG, Greengard P (2007) Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation. J Neurosci 27:4201–4209PubMedCrossRefGoogle Scholar
  53. Tassone A, Madeo G, Schirinzi T, Vita D, Puglisi F, Ponterio G, Borsini F, Pisani A, Bonsi P (2011) Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission. Neuropharmacology. doi: 10.1016/j.neuropharm.2011.05.004
  54. Torquet N, Hagues J, Costentin J (2008) The reduction in electric footshocks perception interferes with the amnesic effect of scopolamine. Behav Brain Res 188:238–240PubMedCrossRefGoogle Scholar
  55. Tulving E (2001) Episodic memory and common sense: how far apart? Philos Trans R Soc Lond B Biol Sci 356:1505–1515PubMedCrossRefGoogle Scholar
  56. Wesolowska A (2008) The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors. Eur J Pharmacol 580:355–360PubMedCrossRefGoogle Scholar
  57. Wesolowska A (2010) Potential role of the 5-HT6 receptor in depression and anxiety; an overview of preclinical data. Pharmacol Rep 62:564–577PubMedGoogle Scholar
  58. Wesolowska A, Nikiforuk A (2007) Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology 52:1274–1283PubMedCrossRefGoogle Scholar
  59. Wesolowska A, Nikiforuk A, Stachowicz K (2007) Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats. Behav Pharmacol 18:439–446PubMedCrossRefGoogle Scholar
  60. Woolley ML, Bentley JC, Sleight AJ, Marsden CA, Fone KC (2001) A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology 41:210–219PubMedCrossRefGoogle Scholar
  61. Woolley ML, Marsden CA, Sleight AJ, Fone KC (2003) Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790. Psychopharmacology (Berl) 170:358–367CrossRefGoogle Scholar
  62. Zhang MY, Hughes ZA, Kerns EH, Lin Q, Beyer CE (2007) Development of a liquid chromatography/tandem mass spectrometry method for the quantitation of acetylcholine and related neurotransmitters in brain microdialysis samples. J Pharm Biomed Anal 44:586–593PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Virginie Da Silva Costa-Aze
    • 1
    • 2
    • 3
  • Anne Quiedeville
    • 1
  • Michel Boulouard
    • 1
  • François Dauphin
    • 1
  1. 1.Groupe Mémoire et Plasticité comportementale (GMPc), EA 4259Université de Caen Basse NormandieCaenFrance
  2. 2.Laboratoire d’hormonologie, Pôle de biologieCentre Hospitalier Universitaire de CaenCaenFrance
  3. 3.Department of HormonologyCHU de Caen, and Medical School, Université de Caen Basse-NormandieCaenFrance

Personalised recommendations